Medicare Enrolled
Dr. Seyed Abedi, M.D.,PH.D.
Medical Oncology · Cedar Park, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abedi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abedi
Dr. Seyed Abedi is a medical oncology specialist in Cedar Park, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Abedi performed 27,961 Medicare services across 1,469 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abedi received a total of $6,390 from 48 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abedi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 31% volume in TX
$6,390 industry payments
Medicare Practice Summary
Medicare Utilization ↗27,961
Medicare services
Top 31% in TX for medical oncology
1,469
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
18,200 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 5,200 | $43 | $137 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
699 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
683 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
594 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $90 | $368 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
354 | $128 | $496 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
234 | $9 | $56 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
138 | $17 | $60 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
128 | $14 | $73 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
126 | $15 | $76 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
118 | $22 | $157 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
112 | $47 | $313 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
112 | $98 | $707 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
86 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
86 | $6 | $34 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $2 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
53 | $10 | $96 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
53 | $6 | $431 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
52 | $4 | $23 |
| New patient office visit, complex (60-74 min) | 47 | $164 | $709 |
| Immunologic analysis of serum A laboratory test that uses immunologic techniques to analyze components in a blood serum sample. |
39 | $29 | $108 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
39 | $22 | $160 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
39 | $24 | $256 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
38 | $11 | $99 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $15 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
37 | $21 | $161 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $25 | $145 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
33 | $19 | $99 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
29 | $1 | $7 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
27 | $56 | $264 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
25 | $10 | $75 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
24 | $18 | $114 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
22 | $16 | $96 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
19 | $5 | $26 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $134 | $694 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $127 | $565 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
86.9% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,390
Total received (2022-2024)
Avg $2,130/year across 3 years
Top 42% in TX for medical oncology
48
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,908 (61.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,725 (27.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$757 (11.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,104
2023
$3,630
2022
$657
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,017
Novartis Pharmaceuticals Corporation
$370
E.R. Squibb & Sons, L.L.C.
$344
Lilly USA, LLC
$312
Astellas Pharma US Inc
$311
Incyte Corporation
$218
PFIZER INC.
$216
Celgene Corporation
$204
Seagen Inc.
$181
Amgen Inc.
$179
Tempus AI, Inc
$175
Takeda Pharmaceuticals U.S.A., Inc.
$162
Janssen Biotech, Inc.
$131
GlaxoSmithKline, LLC.
$120
Eisai Inc.
$112
Regeneron Healthcare Solutions, Inc.
$107
GENZYME CORPORATION
$94
Alexion Pharmaceuticals, Inc.
$78
JAZZ PHARMACEUTICALS INC.
$73
Genentech USA, Inc.
$66
SOBI, INC
$62
Karyopharm Therapeutics Inc.
$61
AVEO Pharmaceuticals, Inc.
$56
BeiGene USA, Inc.
$51
TAIHO ONCOLOGY, INC.
$47
Secura Bio, Inc.
$44
CTI BioPharma Corp.
$43
Bayer Healthcare Pharmaceuticals Inc.
$42
ABBVIE INC.
$42
Aveo Pharmaceuticals, Inc.
$40
Adaptive Biotechnologies Corporation
$40
Rigel Pharmaceuticals, Inc.
$39
Genmab U.S., Inc.
$37
Ipsen Biopharmaceuticals, Inc
$37
Merck Sharp & Dohme LLC
$31
Pharmacyclics LLC, An AbbVie Company
$29
Deciphera Pharmaceuticals Inc.
$24
Blueprint Medicines Corporation
$23
TerSera Therapeutics LLC
$21
Tolmar, Inc.
$20
Stemline Therapeutics Inc.
$19
Gilead Sciences, Inc.
$19
ARRAY BIOPHARMA INC
$19
Octapharma USA, Inc.
$17
MorphoSys, US Inc.
$17
Agios Pharmaceuticals, Inc.
$14
Tactile Systems Technology Inc
$13
EISAI INC.
$13
Top 3 companies account for 42.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · AYVAKIT · Alecensa · BRAFTOVI · BRUKINSA · CALQUENCE · COPIKTRA · DARZALEX · Doptelet · ELIGARD · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Flexitouch Plus · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Rezlidhia · SARCLISA · SCEMBLIX · TECVAYLI · Tecentriq · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VONVENDI · Venclexta · Vonjo · Vyloy · XPOVIO · XTANDI · Xofigo · Xospata · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $23 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
29
Per 100K population
4.5
County median income
$108,309
Nearest hospital
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Abedi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Abedi experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Abedi performed 18,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abedi receive payments from pharmaceutical companies?
Yes. Dr. Abedi received a total of $6,390 from 48 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abedi's costs compare to other medical oncologists in Cedar Park?
Dr. Abedi's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Cedar Park
Browse medical oncologists in Cedar Park ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology